Martingale Asset Management L P Cara Therapeutics, Inc. Transaction History

Martingale Asset Management L P

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$4.89 - $12.27 $68 - $171	-14 Reduced 0.04%	39,025 $191,000
Q4 2022 Feb 13, 2023	BUY	$8.88 - $12.77 $242,770 - $349,119	27,339 Added 233.67%	39,039 $419,000
Q3 2022 Nov 14, 2022	SELL	$8.24 - $12.56 $112,187 - $171,004	-13,615 Reduced 53.78%	11,700 $110,000
Q2 2022 Aug 11, 2022	SELL	$7.45 - $13.84 $248,964 - $462,505	-33,418 Reduced 56.9%	25,315 $231,000
Q1 2022 May 12, 2022	BUY	$9.94 - $12.65 $72,224 - $91,914	7,266 Added 14.12%	58,733 $713,000
Q4 2021 Feb 11, 2022	BUY	$11.99 - $18.14 $29,975 - $45,350	2,500 Added 5.11%	51,467 $626,000
Q3 2021 Nov 12, 2021	BUY	$11.55 - $16.06 $152,540 - $212,104	13,207 Added 36.93%	48,967 $756,000
Q2 2021 Aug 13, 2021	BUY	$12.38 - $29.19 $301,143 - $710,046	24,325 Added 212.72%	35,760 $510,000
Q1 2021 May 13, 2021	BUY	$15.07 - $21.71 $172,325 - $248,253	11,435 New	11,435 $248,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.